Related Experiment Videos
The effect of anti-CD3-immunotoxin on T lymphocyte function in vitro
Transplant Immunology
|June 26, 1998
Summary
This study shows that the novel immunotoxin FN18-CRM9 effectively and specifically eliminates T cells in vitro, inducing apoptosis and cell cycle arrest. These findings support its potential for inducing immunological tolerance.
Area of Science:
- Immunology
- Cell Biology
- Toxicology
Background:
- Immunotoxins (IT) have advanced, with FN18-CRM9 showing improved specificity, reduced toxicity, and high efficacy.
- Previous studies in rhesus macaques suggest anti-CD3 immunotoxin can induce immunological tolerance via T cell ablation.
Purpose of the Study:
- To characterize the in vitro mode of action of the anti-CD3 immunotoxin FN18-CRM9.
- To investigate its effects on T cell killing, proliferation, phenotype, and cytokine production.
Main Methods:
- In vitro analysis of peripheral blood and lymph node T cells.
- Assessment of cytotoxicity, apoptosis (TUNEL assay, DNA content), Fas expression, cell cycle, and cytokine production (IL2, IFN gamma, TNF alpha).
Main Results:
- FN18-CRM9 demonstrated high specificity for T cell killing at low doses (1 x 10^6 µg/ml), with maximal effect at 48 hours.
- Toxicity was restricted to T cells; B cells and bystander cells were spared.
- The immunotoxin induced T cell apoptosis and cell cycle arrest at G1/S phase, suppressing cytokine production and upregulating Fas expression.
Conclusions:
- FN18-CRM9 specifically induces T cell apoptosis and cell cycle arrest, supporting its potential therapeutic use.
- The findings align with in vivo observations regarding the immunotoxin's temporal, specificity, and quantitative patterns.